إسرائيل - العبرية - Ministry of Health

ben shimon floris ltd, israel - chlorhexidine digluconate; isopropanol - תמיסה - isopropanol 70 %v/v; chlorhexidine digluconate 2 %w/v - chlorhexidine

إسرائيل - العبرية - Ministry of Health

teva medical ltd - chlorhexidine gluconate; isopropanol - תמיסה - chlorhexidine gluconate 0.5 %w/v; isopropanol 70 %v/v - chlorhexidine, combinations - chlorhexidine, combinations - skin disinfectant especially for pre-invasive procedures. disinfection of the newly born umbilical cord. disinfection of thermometers.

إسرائيل - العبرية - Ministry of Health

linevitz eliezer - phenylpropanolamine hydrochloride 5 %w/v - syrup - treatment of urinary incontinence associated with urethral sphincter incompetence in the bitch.

إسرائيل - العبرية - Ministry of Health

kamada ltd - aprotinin 10000 kiu / 1 ml - solution for injection - aprotinin - protosol is used in adults in the treatment and prophylaxis of disorders in which inhibition of proteolytic enzymes is indicated: for the early treatment of states of shock. for the prevention of postoperative or post-traumatic complications. to reduce major blood loss in patients undergoing surgery involving cardiopulmonary bypass.

إسرائيل - العبرية - Ministry of Health

gsk consumer healthcare, israel ltd - chlorhexidine digluconate - תמיסה - chlorhexidine digluconate 0.2 %w/v - chlorhexidine - chlorhexidine - antibacterial solution for the disinfection of the mouth.1. as an aid to maintaining oral hygiene.2. as an aid in the treatment and prevention of gingivitis.3. inhibition of formation of dental plaque.4. for use in aphtous ulceration and oral candidal infections (eg denture stomatitis and thrush).5. for use in a post- periodontal surgery or treatment regimen to promote gingival healing.

إسرائيل - العبرية - Ministry of Health

novartis israel ltd - ciclosporin - קפסולות - ciclosporin 50 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.

إسرائيل - العبرية - Ministry of Health

novartis israel ltd - ciclosporin - קפסולות - ciclosporin 100 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.

إسرائيل - العبرية - Ministry of Health

perrigo israel agencies ltd - ciclopirox - לק - ciclopirox 8 %w/w - ciclopirox

إسرائيل - العبرية - Ministry of Health

perrigo israel agencies ltd - ciclopirox - לק - ciclopirox 8 %w/w - ciclopirox

إسرائيل - العبرية - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - hpv type 11 l1 protein; hpv type 16 l1 protein; hpv type 18 l1 protein; hpv type 31 l1 protein; hpv type 33 l1 protein; hpv type 45 l1 protein; hpv type 52 l1 protein; hpv type 58 l1 protein; hpv type 6 l1 protein - תרחיף להזרקה - hpv type 58 l1 protein 20 mcg / 0.5 ml; hpv type 52 l1 protein 20 mcg / 0.5 ml; hpv type 45 l1 protein 20 mcg / 0.5 ml; hpv type 33 l1 protein 20 mcg / 0.5 ml; hpv type 31 l1 protein 20 mcg / 0.5 ml; hpv type 18 l1 protein 40 mcg / 0.5 ml; hpv type 16 l1 protein 60 mcg / 0.5 ml; hpv type 11 l1 protein 40 mcg / 0.5 ml; hpv type 6 l1 protein 30 mcg / 0.5 ml - papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58)